Evoke Pharma, Inc. (EV00.F)

0.3860 -0.0520 (-11.87%) 收市：08:15AM CEST

Evoke Pharma, Inc.

420 Stevens Avenue
Suite 230
Solana Beach, CA 92075
United States
858 345 1494
https://www.evokepharma.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 4

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Matthew J. D'Onofrio MBA	Co-Founder, CEO & Director	726.38k	無	1970
Dr. Marilyn R. Carlson D.M.D., M.D., RAC.	Chief Medical Officer	634.92k	無	1948
Mr. Christopher Quesenberry	Chief Commercial Officer - Gimoti (TM)	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

公司管治

截至 無 止，Evoke Pharma, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。